scholarly journals Prediction of risk of depressive symptoms in menopausal women based on hot flash and sweating symptoms: a multicentre study

2017 ◽  
Vol Volume 12 ◽  
pp. 1993-2001 ◽  
Author(s):  
Yanwei Zheng ◽  
Yibei Zhou ◽  
Jiangshan Hu ◽  
Jieping Zhu ◽  
Qi Hua ◽  
...  
Keyword(s):  
Depressive Symptoms ◽  
Multicentre Study ◽  
Hot Flash ◽  
Menopausal Women

scholarly journals Evidence of hot flash–induced awakenings in menopausal women

2020 ◽  
Vol 16 (S2) ◽  
Author(s):  
Jacob Van Doorn ◽  
Alexandra Paget‐Blanc ◽  
Lauren L. Drogos ◽  
Leah H. Rubin ◽  
Pauline M. Maki
Keyword(s):  
Hot Flash ◽  
Menopausal Women

Phase III Comparison of Depomedroxyprogesterone Acetate to Venlafaxine for Managing Hot Flashes: North Central Cancer Treatment Group Trial N99C7

2006 ◽  
Vol 24 (9) ◽  
pp. 1409-1414 ◽  
Author(s):  
Charles L. Loprinzi ◽  
Ralph Levitt ◽  
Debra Barton ◽  
Jeff A. Sloan ◽  
Shaker R. Dakhil ◽  
...  
Keyword(s):  
Treatment Options ◽  
Hot Flashes ◽  
Phase Iii ◽  
Hot Flash ◽  
Daily Diaries ◽  
North Central ◽  
Intramuscular Dose ◽  
Intention To Treat ◽  
Menopausal Women ◽  
To Receive

Purpose Vasomotor hot flashes are a common problem in menopausal women. Given concerns regarding estrogen and/or combined hormonal therapy, other treatment options are desired. Prior trials have confirmed that progestational agents and newer antidepressants effectively reduce hot flashes. This current trial compared a single intramuscular dose of medroxyprogesterone acetate (MPA), depot preparation, versus daily oral venlafaxine as treatment for hot flashes. Methods Women with bothersome hot flashes were entered onto this trial, were randomly assigned to treatment, and then had a baseline week where hot flash scores were recorded without treatment. They were then treated and observed for 6 weeks; daily diaries were used to measure hot flash frequencies and severities. There were 109 patients per each arm randomly assigned to receive MPA 400 mg intramuscularly for a single dose versus venlafaxine 37.5 mg per day for a week, then 75 mg per day. Results During the sixth week after random assignment, hot flash scores were reduced by 55% in the venlafaxine arm versus 79% in the MPA arm (P < .0001). In an intention-to-treat analysis, 46% of venlafaxine patients (50 of 109) compared with 74% of the MPA patients (81 of 109) had a decrease in hot flashes by more than 50% from baseline (P < .0001). Less toxicity was reported in the MPA arm. Conclusion A single MPA dose seems to be well tolerated and more effectively reduces hot flashes than does venlafaxine.

scholarly journals DEPRESSION;

2018 ◽  
Vol 25 (08) ◽  
pp. 1177-1181
Author(s):  
Ejaz Gul ◽  
Muhammad Muslim Khan ◽  
Mukhtiar Azeemi ◽  
Pirzada Muhammad Muneeb
Keyword(s):  
Depressive Symptoms ◽  
Rating Scale ◽  
Severe Depression ◽  
Cross Sectional Study ◽  
Menopausal Symptoms ◽  
Cross Sectional ◽  
Symptoms Of Depression ◽  
Menopausal Women ◽  
Severity Of Depression ◽  
Accompanying Symptoms

Depression is a common problem among women. Different variables contributein influencing depression among women. Menopause is one variable that may trigger symptomsof depression. Different variables jointly contribute in influencing the presentation of menopausalsymptoms including sociocultural, psychological and environmental factors. No studies havebeen conducted to assess mean age and symptoms of depression among menopausalwomen of Mardan. Objectives: To assess accompanying symptoms of depression and theirseverity among menopausal women. Study Design: Cross-sectional study. Setting: GynaeOut-patient Department at Mardan Medical Complex. Period: February 2017 to October 2017.Methods: The sample consisted of 200 women ranging in age from 45-71 years. Each patientwas assessed using sociodemographic sheet, menopausal symptoms were assessed usingMenopausal rating scale and severity of depression was measured using Hamilton depressionscale. Data was entered and analyzed using SPSS Version 21.0. Results: According to thefindings of this study, mean age at menopause was noted to be 49.1 ranging from 44-59. Amongthe many predominant menopausal symptoms, the most common among these symptomsreported were joint and muscle discomfort in 62% of women, followed by sleep problem (17%),and physical and mental exhaustion (11%). The least reported menopausal symptoms weredrying of vagina, sexual problems and anxiety. Depression was found among 26 % of thefemale participants according to Hamilton scoring criteria. Mild depressive symptoms werenoted among 24%, moderate depressive symptoms 14%, severe 5% and very severe 7%.Conclusion: According to the results of the current study, 50 % of the participants lies in therange of depression according to Hamilton depression scores. Among these 50%, more thanhalf 26 % lies in the range of severe to very severe depression while the rest 24% lies in therange of mild to moderate depression.

Exploring the Relationship between Depression on Menopausal Symptoms and Personality Trails

2021 ◽  
pp. 0272684X2110049
Author(s):  
Niloufar Ahmadi ◽  
Mouloud Agajani Delavar ◽  
Sepideh Mashayekh-Amiri ◽  
Sedighe Esmaeilzadeh
Keyword(s):  
Depressive Symptoms ◽  
Sleep Quality ◽  
Personality Traits ◽  
Postmenopausal Women ◽  
Menopausal Symptoms ◽  
Poor Sleep ◽  
Poor Sleep Quality ◽  
Cross Sectional ◽  
Menopausal Women ◽  
High Level

The aim of the present study was to explore the potential relationships between menopausal symptoms, sleep quality, hot flash, and depressive symptoms in postmenopausal women. A cross-sectional study was designed with 150 healthy postmenopausal women (45–60 years of age) who had referred to the menopausal clinic in Babol. The participants completed the following instruments throughout the study: the Beck Depression Inventory for depressive symptoms, the Modified Blatt-Kupperman Menopausal Index for measuring menopausal symptoms, and the NEO-FFI for identifying the personality traits. After controlling all the covariates, high depressive symptoms were found to be associated with moderate/sever menopausal symptoms, poor sleep quality, and the average and high level of neuroticism. The results also demonstrated that the risk of depressive symptoms was lower in menopausal women with high level extroversion, high level agreeableness, and the average and high level of conscientiousness. The findings of the present study indicated that personality traits, menopausal symptoms, and poor sleep quality in particular can partially account for depression in Iranian menopausal women. It is highly imperative that effective health education or implement appropriate strategies to improve the quality of life for these women.

scholarly journals Exploring the relationship between menopausal symptoms, personality, and depressive symptoms in postmenopausal women

2020 ◽  
Author(s):  
Niloufar Ahmadi ◽  
Mouloud Agajani Delavar ◽  
Sepideh Mashayekh‑Amiri ◽  
Sedighe Esmaeilzadeh
Keyword(s):  
Depressive Symptoms ◽  
Sleep Quality ◽  
Postmenopausal Women ◽  
Cross Sectional Study ◽  
Menopausal Symptoms ◽  
Poor Sleep ◽  
Poor Sleep Quality ◽  
Cross Sectional ◽  
Menopausal Women ◽  
High Level

Abstract Background A quick look at the results of research studies in the existing literature indicates that depression in postmenopausal women can greatly affect their function and self-esteem. The aim of the present study was to explore the potential relationships between menopausal symptoms, sleep quality, hot flash, and depressive symptoms in postmenopausal women.Methods A cross-sectional study was designed with 150 healthy postmenopausal women (45–60 years of age) who had referred to the menopausal clinic in Babol. The participants completed the following instruments throughout the study: the Beck Depression Inventory for depressive symptoms, the Modified Blatt-Kupperman Menopausal Index for measuring menopausal symptoms, and the NEO-FFI for identifying the personality traits.Results After controlling all the covariates, high depressive symptoms were found to be associated with moderate/ sever menopausal symptoms, poor sleep quality, and the average and high level of neuroticism. The results also demonstrated that the risk of depressive symptoms was lower in menopausal women with high level extroversion, high level agreeableness, and the average and high level of conscientiousness.Conclusions The findings of the present study indicated that personality traits, menopausal symptoms, and poor sleep quality in particular can partially account for depression in Iranian menopausal women.

Evaluating the Sleep Hygiene Awareness and Practice Scale in Midlife Women With and Without Breast Cancer

2016 ◽  
Vol 24 (2) ◽  
pp. 258-267
Author(s):  
Julie L. Otte ◽  
Jingwei Wu ◽  
Menggang Yu ◽  
Claire Shaw ◽  
Janet S. Carpenter
Keyword(s):  
Breast Cancer ◽  
Cancer Survivors ◽  
Breast Cancer Survivors ◽  
Sleep Hygiene ◽  
Midlife Women ◽  
Poor Sleep ◽  
Cross Sectional ◽  
Hot Flash ◽  
Hygiene Practices ◽  
Menopausal Women

Background and Purpose: Sleep hygiene is one factor that contributes to poor sleep in breast cancer survivors but is poorly measured. The purposes of this study were to (a) evaluate the psychometric properties of the Sleep Hygiene Awareness and Practice Scale (SHAPS) and (b) compare SHAPS scores between midlife women with and without breast cancer. Methods: Cross-sectional, descriptive data from a single-blinded, controlled hot flash intervention trial. Results: 194 women (88 breast cancer survivors; 106 menopausal women). Reliability of the three sections of the SHAPS was inadequate with Cronbach’s alphas ranging from 0.23 to 0.67. Sleep hygiene practices were modestly correlated with global sleep quality in both groups. Conclusions: Findings suggest the SHAPS would need to be revised to be a psychometrically sound measure of sleep hygiene awareness and practice.

Sign in / Sign up

Export Citation Format

Share Document